Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma”

Bibliographic Details
Main Authors:	Francisco M. Vega, Ana Colmenero-Repiso, María A. Gómez-Muñoz, Ismael Rodríguez-Prieto, Diana Aguilar-Morante, Gema Ramírez, Catalina Márquez, Rosa Cabello, Ricardo Pardal
Format:	Article
Language:	English
Published:	Elsevier 2020-03-01
Series:	EBioMedicine
Subjects:	Neuroblastoma CD44 expression Undifferentiation Survival
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396420300785

Internet